TOP STORIES

• ORGANIZATION Kenporen’s Kono Pushes for “Huge Seller” Re-Pricing for Opdivo before 2018
  September 7, 2016

• REGULATORY 6 National Centers Log Generic Use Rate of Average 73.8% in FY2015
  September 6, 2016

• BUSINESS Oncolys to Evaluate Oncolytic Virus in Combination with Immune Checkpoint Inhibitors; Interim Results Expected in 2017
  September 5, 2016

• BUSINESS Otsuka, RIKEN Open Collaborative Research Center to Promote Regenerative Medicine
  September 2, 2016

• BUSINESS Harvoni Outstrips Plavix to Top FY2015 Japan Sales Ranking: Jiho Tally
  September 1, 2016

• REGULATORY Lilly Drops Listing of Taltz amid Pricing Fuss, Wants to Deliver Drug without Restrictions
  August 31, 2016

• REGULATORY MHLW Panel to Discuss Keytruda on Sept. 9, Listing Expected as Early as November
  August 30, 2016

• BUSINESS Sizzling DOAC Market - 4: Companies Aim to Differentiate Their Products through Quality of Information
  August 29, 2016

• BUSINESS Sizzling DOAC Market - 3: Dosage and Administration Vary by Product for PE/DVT Treatment
  August 26, 2016

• REGULATORY Chuikyo Subcommittee Effectively Kicks Off Debates on FY2018 Reform, with Focus on Pricy Meds
  August 25, 2016

• REGULATORY After Taltz Given High Price, MHLW to Push Use of Other Psoriasis Drugs; Revision to Foreign Price Adjustment Eyed
  August 25, 2016

• REGULATORY Chuikyo OKs Praluent, 8 Other APIs for Listing on Aug. 31
  August 24, 2016

• BUSINESS Sizzling DOAC Market - 1: Japan Sales Reaching 140 Billion Yen on 4-Way Fight
  August 24, 2016

• REGULATORY MHLW to Seek Funding to Promote and Support Healthcare Startups in FY2017 Budget Request
  August 23, 2016

• REGULATORY MHLW Set to Defend “High-Level Investment” Credits for Key R&D Tax Break System in FY2017 Reform
  August 22, 2016

• BUSINESS Evidence for Actair Sublingual Tablets “Sets It Apart from Other Therapies”: Shionogi
  August 22, 2016

• BUSINESS Amgen Confident of Getting Handsome Slice of Japan Biosimilar Market: Exec
  August 19, 2016

• INTERVIEW Interview: Ex-Astellas Boss Takenaka Urges Mid-Size Makers to Be More Open to Academia in Pathological Research
  August 18, 2016

• REGULATORY AMED Taking Steps toward “Aggressive Intellectual Property Management”: IP Department Head
  August 18, 2016

• BUSINESS CEO of Teva-Takeda JV Confident on Handling Both Long-Listed Brands, Generics
  August 17, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 148
• 149
• 150
• 151
• 152
• 153
• 154
• 155
• 156
• …
• Next ›
• 最終 »